Department of Internal Medicine, National Taiwan University Hospital and National Taiwan University College of Medicine, Taipei, Taiwan.
J Thorac Cardiovasc Surg. 2010 Nov;140(5):1125-32.e2. doi: 10.1016/j.jtcvs.2010.07.017. Epub 2010 Aug 13.
The application of extracorporeal membrane oxygenation in adults has been increasing, but infections occurring during extracorporeal membrane oxygenation use are rarely described.
We retrospectively analyzed the prospectively collected data on nosocomial infection surveillance of 334 patients aged 16 years or more undergoing their first extracorporeal membrane oxygenation for more than 48 hours at a university hospital from 1996 to 2007 for respiratory (20.4%) and cardiac (79.6%) support.
During a total of 2559 extracorporeal membrane oxygenation days, 55 episodes of infections occurred in 45 patients (13.5%), including 38 bloodstream (14.85 per 1000 extracorporeal membrane oxygenation days), 6 surgical site, 4 respiratory tract, 3 urinary tract, and 4 other infections. Stenotrophomonas maltophilia (16.7%) and Candida species (14.6%) were the predominant blood isolates. In stepwise logistic regression analysis, longer duration of extracorporeal membrane oxygenation use (odds ratio 1.003; 95% confidence interval, 1.001-1.005; P = .004), mechanical complications (odds ratio, 4.849; 95% confidence interval, 1.569-14.991; P = .006), autoimmune disease (odds ratio, 6.997; 95% confidence interval, 1.541-31.766; P = .012), and venovenous mode (odds ratio, 4.473; 95% confidence interval, 1.001-19.977; P = .050) were independently associated with a higher risk for infections during extracorporeal membrane oxygenation use. Overall in-hospital mortality was 68.3%, and its independent risk factors included older age (odds ratio, 1.037; 95% confidence interval, 1.021-1.054; P < .001), neurologic complications (odds ratio, 51.153; 95% confidence interval, 6.773-386.329; P < .001), and vascular complications (odds ratio, 1.922; 95% confidence interval, 1.112-3.320; P < .001), but not infections during extracorporeal membrane oxygenation use.
Bloodstream infection was the most common infection during extracorporeal membrane oxygenation use. Duration of extracorporeal membrane oxygenation, mechanical complications, autoimmune disease, and venovenous mode seemed to be independently associated with infections.
体外膜肺氧合在成人中的应用日益增多,但体外膜肺氧合期间发生的感染很少被描述。
我们回顾性分析了 1996 年至 2007 年期间,在一所大学医院接受首次体外膜肺氧合治疗的年龄在 16 岁及以上的 334 例患者的前瞻性收集的医院感染监测数据,这些患者接受体外膜肺氧合治疗的时间超过 48 小时,用于呼吸(20.4%)和心脏(79.6%)支持。
在总共 2559 天的体外膜肺氧合期间,45 例患者发生了 55 例感染(13.5%),包括 38 例血流感染(每 1000 天体外膜肺氧合 14.85 例)、6 例手术部位感染、4 例呼吸道感染、3 例尿路感染和 4 例其他感染。嗜麦芽窄食单胞菌(16.7%)和念珠菌属(14.6%)是主要的血培养分离株。在逐步逻辑回归分析中,体外膜肺氧合使用时间较长(比值比 1.003;95%置信区间,1.001-1.005;P=0.004)、机械并发症(比值比,4.849;95%置信区间,1.569-14.991;P=0.006)、自身免疫性疾病(比值比,6.997;95%置信区间,1.541-31.766;P=0.012)和静脉-静脉模式(比值比,4.473;95%置信区间,1.001-19.977;P=0.050)与体外膜肺氧合期间感染的风险增加独立相关。总体院内死亡率为 68.3%,其独立危险因素包括年龄较大(比值比,1.037;95%置信区间,1.021-1.054;P<0.001)、神经并发症(比值比,51.153;95%置信区间,6.773-386.329;P<0.001)和血管并发症(比值比,1.922;95%置信区间,1.112-3.320;P<0.001),但与体外膜肺氧合期间的感染无关。
血流感染是体外膜肺氧合期间最常见的感染。体外膜肺氧合的持续时间、机械并发症、自身免疫性疾病和静脉-静脉模式似乎与感染独立相关。